# Assembly Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/assembly-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: San Francisco, US
- Website: www.assemblypharmaceuticals.com
- Latest round: Seed (Apr 10, 2014)
- Investors on record: 3

## About

Assembly Pharmaceuticals develops innovative biopharmaceutical solutions aimed at addressing significant health challenges through advanced technology and research.Assembly Pharmaceuticals was founded in 2012 in San Francisco, US, and focuses on biopharmaceutical development. In April 2014, the company raised seed funding from notable investors, including Johnson & Johnson Development Corporation and BioCrossroads. The firm has completed one deal to date.Assembly Pharmaceuticals specializes in advanced biopharmaceutical products designed to enhance healthcare delivery and patient outcomes. Their innovative solutions target areas such as disease management, therapeutic development, and personalized medicine, catering to healthcare providers, hospitals, and research institutions. The company serves clients across North America, Europe, and select regions in Asia, addressing the increasing demand for effective health solutions.The company utilizes a structured revenue generation model, primarily through direct sales and partnerships with healthcare providers. Clients engage in long-term agreements, allowing them access to various biopharmaceutical products and services. This model promotes a stable revenue flow as clients are encouraged to renew their contracts annually, further solidifying the company’s financial framework.Assembly Pharmaceuticals aims to expand its product line with new biopharmaceutical solutions set to launch by the end of 2025. The company is targeting expansion into European and Asian markets, specifically in countries like Germany and Japan, with plans to establish a stronger presence by 2026. The seed funding raised in April 2014 will be allocated towards product development and market entry strategies, supporting these growth initiatives.

## Funding rounds

- Seed, Apr 10, 2014 — Johnson & Johnson Innovation, BioCrossroads, Twilight Venture Partners

## Investors

- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Seed
- BioCrossroads (https://capitalatlas.ai/funds/biocrossroads) — Seed
- Twilight Venture Partners (https://capitalatlas.ai/funds/twilight-venture-partners) — Seed